Protein applications Flashcards

1
Q

Why are therapeutics proteins used rather than small molecules?

A

Many small molecules are inhibitors of proteins.
But proteins have complex functions that cannot be performed by small molecules.
Proteins form specific interactions, and can replace enzyme activities.
Proteins can block protein-protein interactions, and this is difficult for small molecules.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the functions of proteins with enzymatic activity?

A

Replace a deficient protein.
Augment an existing pathway.
Provide a novel activity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Where are proteins sourced from?

A

May be purified from natural sources or recombinant - unlimited supply, safe.
Can be wild type or modified to enhance properties.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is insulin?

A

Small protein - 51 amino acids.
Produced by pancreatic B-cells.
Stimulates glycogenesis and inhibits glucose production.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is type 1 diabetes?

A

B cells are destroyed and insulin is not produced.
Causes high blood sugar levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is pancreatic insufficiency?

A

Caused by:
Pancreatitis - if pancreas is removed, can’t release digestive enzymes into small intestine.
Pancreatectomy
Cystic fibrosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the treatment for pancreatic insufficiency?

A

Extract of digestive enzymes - chymotrypsin, amylase, lipase - is made into enteric-coated capsules - Pancrelipase.
This goes through stomach without being digested, then released in stomach.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is a1 antitrypsin?

A

Protein synthesised by liver.
Inhibits neutrophil elastase.
Mutations cause misfolding and prevent secretion, so there is too much neutrophil elastase, causes liver damage and lung damage - COPD.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is a1-antitrypsin deficiency treatment?

A

Intravenous infusin of a1 antitrypsin, cannot be orally taken as would be digested.
Does not reverse the damage of the disease, but prevents progression.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the theme of therapeutic proteins?

A

Break down unwanted things in the body.
E.g. asparaginase breaks down asparagine to aspartate, so leukemia cells can’t proliferate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the benefits of recombinant therapeutic proteins?

A

Safer, limitless supply, can be modified:
Point mutations can be introduced to alter activity and stability.
Alter glycosylation to alter stability.
Pegylation to increase half-life - bigger and more soluble.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are chimeric proteins?

A

Can alter proteins so that they perform the functions of other proteins, within one protein.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is Herceptin?

A

Humanised anti-Her2 antibody.
HER2 oncoprotein is overexpressed in many cancers.
It is a Receptor tyrosine kinase, activated by dimerisation, drives cancer proliferation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are antibody drug conjugates (ADCs)?

A

Attach antibody to toxic cargo - binds to cell surface proteins on diseased cells, delivers toxin to cells, so cell dies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are immune checkpoint inhibitors?

A

Cancer cell presents antigenic peptides to T cell.
T cell recognises antigen and destroys the cancer cell.
But molecules interact with T cell and prevent it from killing cancer.
By inhibiting these molecules, can destroy the tumour cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the challenges with protein therapeutics?

A

Immunogenicity - immune response may limit efficacy.
Cannot permeate cell membrane or blood-brain barrier.
Safe production and cost.
Delivery - injection or infusion is required.

17
Q

What is a biomarker?

A

A molecular change that can measured by a test, which informs on medical decision making.
Can be DNA, RNA, but mostly proteins.

18
Q

What are the functions of biomarkers?

A

Diagnostic - detects presence of disease.
Prognostic - indicates likely course of disease.
Predictive - predicts the response to therapy.

19
Q

What are lab tests?

A

Blood sample
Use enzyme linked assays or antibody based methods to test blood, compare to normal reference level.

20
Q

What is C-reactive protein?

A

Made in liver
Binds phosphocholine, activates complement cascade.
Acute inflammatory marker - indicates there is infection or inflammation and treatment is needed.

21
Q

How is blood used as a biomarker?

A

Blood screening for colorectal cancer - if haemoglobin present then possible indication of colorectal cancer.
Blood in urine can possibly indicate bladder cancer.

22
Q

What are biomarkers of liver function?

A

Albumin is a component of blood plasma - liver disease - decreased albumin.
Increased aspartate transaminase, alanine transaminase and alkaline phosphatase can all indicate liver disease.

23
Q

How can biomarkers be used to detect a heart attack?

A

Proteins released from heart muscle show myocardial infarction.
Troponin I and T are components of thin filaments of cardiac muscle, shows heart muscle damaged.

24
Q

What are cancer biomarkers?

A

Tissue leakage produces Prostate specific antigen (PSA).
Increased plasma levels due to leakage from the prostate.
Elevated levels can indicate benign prostatic hyperplasia.

25
Q

What are the pros of protein cancer biomarkers?

A

Easy and cheap to measure.
Can be very fast.
Non-invasive disease detection
Longitudinal monitoring of disease.

26
Q

What are the cons of protein cancer biomarkers in body fluids?

A

Moderate sensitivity and specificity.
Limited use in screening and early detection.
Limited information on biology of disease.

27
Q

What are the uses of immunohistochemistry protein biomarkers in cancer?

A

Aids diagnosis
Cancer subtyping
Tissue of origin
Prognosis - how aggressive tumour is.
Predicting response to treatment
Precision medicine.

28
Q

What are the limitations of protein biomarkers in cancer?

A

Need good antibiotics
Only one or a small number of markers.
Qualitative and operator dependent.

29
Q

What are the positives of immunohistochemistry protein biomarkers in cancer?

A

Simple and low cost
Proteins are the end points of genomic changes.